For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Rabbit polyclonal to C22orf29
Recombinant fragment, corresponding to amino acids 71-195 of Human C22orf29 (Q7L3V2).
- RT4 cell lysate, Human heart muscle tissue
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.02% Sodium azide
Constituents: 59% PBS, 40% Glycerol
Concentration information loading...
Immunogen affinity purified
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||Use at an assay dependent concentration.
||Use a concentration of 1 - 4 µg/ml.
Recommend PFA Fixation and Triton X-100 treatment
||1/50 - 1/200. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. Use buffer at pH 6 for antigen retrieval.
Information by UniProt
- C22orf29 antibody
- CV029_HUMAN antibody
- Uncharacterized protein C22orf29 antibody
Immunocytochemistry/ Immunofluorescence - Anti-C22orf29 antibody (ab121113)
Immunofluorescent staining of Human cell line A-431 shows positivity in cytoplasm. Recommended concentration of ab121113 1-4 µg/ml. Cells treated with PFA/Triton X-100.
Western blot - Anti-C22orf29 antibody (ab121113)
All lanes : Anti-C22orf29 antibody (ab121113) at 1/250 dilution
Lane 1 : RT4 cell lysate
Lane 2 : EFO-21 cell lysate
Lane 3 : A431 cell lysate
Lane 4 : Human Liver lysate
Lane 5 : Human Tonsil lysate
Developed using the ECL technique
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C22orf29 antibody (ab121113)
ab121113 at 1/150 dilution staining C22orf29 in Paraffin-emebedded Human heart muscle tissue by Immunohistochemistry.
Note: cytoplasmic positivity in myocytes.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"